{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T04:47:19Z","timestamp":1776142039111,"version":"3.50.1"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"KFSHRC institutional funds","award":["RAC#2100024"],"award-info":[{"award-number":["RAC#2100024"]}]},{"name":"KFSHRC institutional funds","award":["2140015"],"award-info":[{"award-number":["2140015"]}]},{"name":"KFSHRC institutional funds","award":["10BIO1350-20"],"award-info":[{"award-number":["10BIO1350-20"]}]},{"name":"KFSHRC institutional funds","award":["13MED456-20"],"award-info":[{"award-number":["13MED456-20"]}]},{"name":"King Abdullaziz City"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology Letters"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.toxlet.2017.08.011","type":"journal-article","created":{"date-parts":[[2017,8,16]],"date-time":"2017-08-16T13:45:50Z","timestamp":1502891150000},"page":"151-158","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Rosiglitazone promotes cardiac hypertrophy and alters chromatin remodeling in isolated cardiomyocytes"],"prefix":"10.1016","volume":"280","author":[{"given":"Lama Fawaz","family":"Pharaon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naglaa Fathi","family":"El-Orabi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Kunhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadya","family":"Al Yacoub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salma Mahmoud","family":"Awad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Coralie","family":"Poizat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.toxlet.2017.08.011_bib0005","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1440-1681.2004.03954.x","article-title":"An antidiabetic thiazolidinedione induces eccentric cardiac hypertrophy by cardiac volume overload in rats","volume":"31","author":"Arakawa","year":"2004","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.toxlet.2017.08.011_bib0010","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1479-5876-4-10","article-title":"Hydralazine target: from blood vessels to the epigenome","volume":"4","author":"Arce","year":"2006","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.toxlet.2017.08.011_bib0015","doi-asserted-by":"crossref","first-page":"7656","DOI":"10.1093\/nar\/gkt500","article-title":"Nuclear CaMKII enhances histone H3 phosphorylation and remodels chromatin during cardiac hypertrophy","volume":"41","author":"Awad","year":"2013","journal-title":"Nucl. Acids Res."},{"key":"10.1016\/j.toxlet.2017.08.011_bib0020","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/path.4489","article-title":"Control of histone H3 phosphorylation by CaMKIIdelta in response to haemodynamic cardiac stress","volume":"235","author":"Awad","year":"2015","journal-title":"J. Pathol."},{"key":"10.1016\/j.toxlet.2017.08.011_bib0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vascn.2007.01.003","article-title":"Rodent models of heart failure","volume":"56","author":"Balakumar","year":"2007","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.toxlet.2017.08.011_bib0030","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1097\/HJR.0b013e32833158a2","article-title":"Pathological and physiological hypertrophies are regulated by distinct gene programs","volume":"16","author":"Beisvag","year":"2009","journal-title":"Eur. J. Cardiovasc. Prev. Rehabil."},{"key":"10.1016\/j.toxlet.2017.08.011_bib0035","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ejphar.2004.12.027","article-title":"Effects of rosiglitazone and interactions with growth-regulating factors in ventricular cell hypertrophy","volume":"508","author":"Bell","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.toxlet.2017.08.011_bib0040","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1101\/gad.1787609","article-title":"An operational definition of epigenetics","volume":"23","author":"Berger","year":"2009","journal-title":"Genes Dev."},{"key":"10.1016\/j.toxlet.2017.08.011_bib0045","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.pharmthera.2010.04.005","article-title":"Molecular distinction between physiological and pathological cardiac hypertrophy: experimental findings and therapeutic strategies","volume":"128","author":"Bernardo","year":"2010","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.toxlet.2017.08.011_bib0050","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.cell.2005.01.001","article-title":"Genomic maps and comparative analysis of histone modifications in human and mouse","volume":"120","author":"Bernstein","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.toxlet.2017.08.011_bib0055","doi-asserted-by":"crossref","first-page":"re4","DOI":"10.1126\/stke.2812005re4","article-title":"Inducible covalent posttranslational modification of histone H3","volume":"2005","author":"Bode","year":"2005","journal-title":"Sci. STKE"},{"key":"10.1016\/j.toxlet.2017.08.011_bib0060","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0092-8674(00)00118-5","article-title":"Signaling to chromatin through histone modifications","volume":"103","author":"Cheung","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.toxlet.2017.08.011_bib0065","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.2337\/dc07-1868","article-title":"Effects of ramipril and rosiglitazone on cardiovascular and renal outcomes in people with impaired glucose tolerance or impaired fasting glucose: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial","volume":"31","author":"Dagenais","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.toxlet.2017.08.011_bib0070","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2174\/1568026033392246","article-title":"Pharmacology and therapeutic applications of A1 adenosine receptor ligands","volume":"3","author":"Dhalla","year":"2003","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.toxlet.2017.08.011_bib0075","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/S0140-6736(05)67528-9","article-title":"Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial","volume":"366","author":"Dormandy","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.toxlet.2017.08.011_bib0080","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1161\/01.RES.0000179226.34112.6d","article-title":"Cardiomyocyte-specific knockout and agonist of peroxisome proliferator-activated receptor-gamma both induce cardiac hypertrophy in mice","volume":"97","author":"Duan","year":"2005","journal-title":"Circ. Res."},{"key":"10.1016\/j.toxlet.2017.08.011_bib0085","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ejim.2006.09.007","article-title":"Thiazolidinediones for the treatment of type 2 diabetes","volume":"18","author":"Elte","year":"2007","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.toxlet.2017.08.011_bib0090","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.bcp.2005.03.033","article-title":"Receptor-independent actions of PPAR thiazolidinedione agonists: is mitochondrial function the key?","volume":"70","author":"Feinstein","year":"2005","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.toxlet.2017.08.011_bib0095","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.yjmcc.2009.04.011","article-title":"Rosiglitazone-induced heart remodelling is associated with enhanced turnover of myofibrillar protein and mTOR activation","volume":"47","author":"Festuccia","year":"2009","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.toxlet.2017.08.011_bib0100","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1146\/annurev.physiol.65.092101.142243","article-title":"Cardiac hypertrophy: the good the bad, and the ugly","volume":"65","author":"Frey","year":"2003","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.toxlet.2017.08.011_bib0105","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/S0140-6736(06)69420-8","article-title":"Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial","volume":"368","author":"Gerstein","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.toxlet.2017.08.011_bib0110","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1046\/j.1365-201X.2003.01161.x","article-title":"Peroxisome proliferators-activated receptors (PPARs): regulators of gene expression in heart and skeletal muscle","volume":"178","author":"Glide","year":"2003","journal-title":"Acta Physiol."},{"key":"10.1016\/j.toxlet.2017.08.011_bib0115","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/nrm1983","article-title":"Regulation of cardiac hypertrophy by intracellular signalling pathways","volume":"7","author":"Heineke","year":"2006","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.toxlet.2017.08.011_bib0120","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1126\/science.1063127","article-title":"Translating the histone code","volume":"293","author":"Jenuwein","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.toxlet.2017.08.011_bib0125","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1038\/nature03877","article-title":"A high-resolution map of active promoters in the human genome","volume":"436","author":"Kim","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.toxlet.2017.08.011_bib0130","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0092-8674(00)81958-3","article-title":"Twenty-five years of the nucleosome: fundamental particle of the eukaryote chromosome","volume":"98","author":"Kornberg","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.toxlet.2017.08.011_bib0135","doi-asserted-by":"crossref","first-page":"40749","DOI":"10.1074\/jbc.M505593200","article-title":"Procainamide is a specific inhibitor of DNA methyltransferase 1","volume":"280","author":"Lee","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.toxlet.2017.08.011_bib0140","doi-asserted-by":"crossref","first-page":"29681","DOI":"10.1074\/jbc.M201517200","volume":"277","author":"Lennon","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.toxlet.2017.08.011_bib0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0029055","article-title":"Stretch-Induced hypertrophy activates NFkB-Mediated VEGF secretion in adult cardiomyocytes","volume":"6","author":"Leychenko","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.toxlet.2017.08.011_bib0150","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/0022-2828(78)90393-0","article-title":"Studies of nuclear proteins in the heart of the cardiomyopathic Syrian hamster\u2013phosphorylation of histones","volume":"10","author":"Liew","year":"1978","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.toxlet.2017.08.011_bib0155","doi-asserted-by":"crossref","first-page":"d1309","DOI":"10.1136\/bmj.d1309","article-title":"Comparative cardiovascular effects of thiazolidinediones: systematic review and meta-analysis of observational studies","volume":"342","author":"Loke","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.toxlet.2017.08.011_bib0160","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1146\/annurev.physiol.63.1.391","article-title":"Cytoplasmic signaling pathways that regulate cardiac hypertrophy","volume":"63","author":"Molkentin","year":"2001","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.toxlet.2017.08.011_bib0165","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1146\/annurev.med.52.1.239","article-title":"New oral therapies for type 2 diabetes mellitus: the glitazones or insulin sensitizers","volume":"52","author":"Mudaliar","year":"2001","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.toxlet.2017.08.011_bib0170","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1161\/01.CIR.0000103683.99399.7E","article-title":"Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association. October 7, 2003","volume":"108","author":"Nesto","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.toxlet.2017.08.011_bib0175","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.tig.2004.02.007","article-title":"Phosphorylation of histone H3: a balancing act between chromosome condensation and transcriptional activation","volume":"20","author":"Nowak","year":"2004","journal-title":"Trends Genet."},{"key":"10.1016\/j.toxlet.2017.08.011_bib0180","doi-asserted-by":"crossref","first-page":"144","DOI":"10.4330\/wjc.v3.i5.144","article-title":"PPARgamma activator, rosiglitazone: is it beneficial or harmful to the cardiovascular system?","volume":"3","author":"Palee","year":"2011","journal-title":"World J. Cardiol."},{"key":"10.1016\/j.toxlet.2017.08.011_bib0185","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1038\/sj.bjp.0702932","article-title":"Therapeutic index for rosiglitazone in dietary obese rats: separation of efficacy and haemodilution","volume":"128","author":"Pickavance","year":"1999","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.toxlet.2017.08.011_bib0190","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1128\/MCB.25.7.2673-2687.2005","article-title":"Phosphorylation-dependent degradation of p300 by doxorubicin-activated p38 mitogen-activated protein kinase in cardiac cells","volume":"25","author":"Poizat","year":"2005","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.toxlet.2017.08.011_bib0195","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1126\/science.1200708","article-title":"Transient regenerative potential of the neonatal mouse heart","volume":"331","author":"Porrello","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.toxlet.2017.08.011_bib0200","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.phrs.2009.11.012","article-title":"Molecular targets and regulators of cardiac hypertrophy","volume":"61","author":"Rohini","year":"2010","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.toxlet.2017.08.011_bib0205","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1161\/01.RES.51.6.787","article-title":"Myocyte hypertrophy in neonatal rat heart cultures and its regulation by serum and by catecholamines","volume":"51","author":"Simpson","year":"1982","journal-title":"Circ. Res."},{"key":"10.1016\/j.toxlet.2017.08.011_bib0210","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/j.intimp.2008.03.010","article-title":"Toxicogenomics \u2212 a novel opportunity to probe lupus susceptibility and pathogenesis","volume":"8","author":"Tsay","year":"2008","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.toxlet.2017.08.011_bib0215","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0092-8674(01)00404-4","article-title":"Activation of cardiac gene expression by myocardin: a transcriptional cofactor for serum response factor","volume":"105","author":"Wang","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.toxlet.2017.08.011_bib0220","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.amjhyper.2004.04.010","article-title":"Beneficial and deleterious effects of rosiglitazone on hypertension development in spontaneously hypertensive rats","volume":"17","author":"Wu","year":"2004","journal-title":"Am. J. Hypertens"},{"key":"10.1016\/j.toxlet.2017.08.011_bib0225","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1056\/NEJMra041001","article-title":"Thiazolidinediones","volume":"351","author":"Yki-Jarvinen","year":"2004","journal-title":"N. Engl. J. Med."}],"container-title":["Toxicology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037842741731247X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037842741731247X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T03:46:50Z","timestamp":1659325610000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S037842741731247X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":45,"alternative-id":["S037842741731247X"],"URL":"https:\/\/doi.org\/10.1016\/j.toxlet.2017.08.011","relation":{},"ISSN":["0378-4274"],"issn-type":[{"value":"0378-4274","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rosiglitazone promotes cardiac hypertrophy and alters chromatin remodeling in isolated cardiomyocytes","name":"articletitle","label":"Article Title"},{"value":"Toxicology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxlet.2017.08.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}